DEBITO Cambiamento Data
Acadia Pharmaceuticals USD 73.85M 23.06M 2026-06
Alaunos Therapeutics USD 10.99M 5.78M 2023-03
ANI Pharmaceuticals USD 607.23M 3.26M 2026-09
Ardelyx USD 256.19M 47.93M 2026-06
Aurora Cannabis CAD 22.68M 1.18M 2026-06
BioMarin Pharmaceutical USD 4.19B 11.99M 2026-09
Bristol-Myers Squibb USD 42.88B 2.18B 2026-09
Canopy Growth CAD 277.33M 1.38M 2026-06
Corcept Therapeutics USD 8.99M 430K 2026-09
Eli Lilly USD 54.91B 11.54B 2026-06
J&J USD 49.04B 5.95B 2026-06
Knight Therapeutics CAD 77.91M 28.33M 2025-12
Lexicon Pharmaceuticals USD 99.51M 243K 2023-12
Merck USD 53.91B 4.79B 2026-06
Nektar Therapeutics USD 0 0 2022-06
Novartis USD 49.01B 2.02B 2026-06
Novartis USD 48.31B 1.31B 2026-09
Omeros USD 442.16M 199K 2023-09
Pacira USD 293.59M 69.53M 2026-09
Pfizer USD 62.67B 523M 2026-09
Supernus Pharmaceuticals USD 40.17M 733K 2026-06
TG Therapeutics USD 754.44M 884K 2026-06